Alphabet
Mountain View, CAfiles as Alphabet Inc.
$99.1bn in 28 US stocks at the end of 30 June 2026. The top 10 are 99.5% of the money. It changed about 95.2% of the portfolio this quarter.
Value
$99.1bn
Stocks
28
Top 10 share
99.5%
Turnover
95.2%
What changed this quarter
New
Bought for the first time this quarter.
- Space Exploration TechnologiesSPCX95.0% of the fund
- Parabilis MedicinesPBLS0.1% of the fund
- Fervo EnergyFRVO<0.1% of the fund
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
- Revolution MedicinesRVMD0.6% of the fund-11%
- Ethos TechnologiesLIFE<0.1% of the fund-4%
- Relay TherapeuticsRLAY<0.1% of the fund-10%
- Monte Rosa TherapeuticsGLUE<0.1% of the fund-46%
Sold out
Sold their entire stake.
Holdings
- Space Exploration TechnologiesSPCX
- Share
- 95.0%
- Value
- $94.2bn
- Shares
- 551,189,500
New
- ARM HoldingsARM
- Share
- 0.7%
- Value
- $695m
- Shares
- 1,960,784
Held
- Parabilis MedicinesPBLS
- Share
- 0.1%
- Value
- $135m
- Shares
- 4,919,498
New
- Fervo EnergyFRVO
- Share
- <0.1%
- Value
- $51m
- Shares
- 1,760,732
New
- Autolus TherapeuticsAUTL
- Share
- <0.1%
- Value
- $1m
- Shares
- 698,262
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Space Exploration TechnologiesSPCX | 95.0% | $94.2bn | 551,189,500 | New |
| Planet Labs PBCPL | 1.2% | $1.2bn | 35,248,893 | Held |
| AST SpaceMobileASTS | 0.8% | $795m | 8,943,486 | Held |
| CME GroupCME | 0.8% | $769m | 3,484,020 | Held |
| ARM HoldingsARM | 0.7% | $695m | 1,960,784 | Held |
| Revolution MedicinesRVMD | 0.6% | $552m | 2,946,619 | -11% |
| FreshworksFRSH | 0.2% | $164m | 16,206,643 | Held |
| Parabilis MedicinesPBLS | 0.1% | $135m | 4,919,498 | New |
| Tempus AITEM | <0.1% | $90m | 1,551,102 | Held |
| GitlabGTLB | <0.1% | $83m | 2,724,712 | Held |
| UiPathPATH | <0.1% | $76m | 7,034,337 | Held |
| Ethos TechnologiesLIFE | <0.1% | $66m | 3,622,604 | -4% |
| Prime MedicinePRME | <0.1% | $61m | 16,562,498 | Held |
| Fervo EnergyFRVO | <0.1% | $51m | 1,760,732 | New |
| PayPayPAYP | <0.1% | $45m | 3,125,000 | Held |
| Maze TherapeuticsMAZE | <0.1% | $41m | 1,388,583 | Held |
| Relay TherapeuticsRLAY | <0.1% | $26m | 1,410,029 | -10% |
| BridgeBio Oncology TherapeuticsBBOT | <0.1% | $22m | 2,823,126 | Held |
| Oscar HealthOSCR | <0.1% | $14m | 481,988 | Held |
| Beam TherapeuticsBEAM | <0.1% | $11m | 321,604 | Held |
| Vera TherapeuticsVERA | <0.1% | $10m | 241,264 | Held |
| Sana BiotechnologySANA | <0.1% | $10m | 2,812,500 | Held |
| Monte Rosa TherapeuticsGLUE | <0.1% | $9m | 372,474 | -46% |
| Lyell ImmunopharmaLYEL | <0.1% | $4m | 293,256 | Held |
| FigmaFIG | <0.1% | $4m | 215,582 | Held |
| Spero TherapeuticsSPRO | <0.1% | $2m | 889,979 | Held |
| HyperfineHYPR | <0.1% | $1m | 898,720 | Held |
| Autolus TherapeuticsAUTL | <0.1% | $1m | 698,262 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 4540.3% since 30 June 2025.
Where the money is
Technology97.4%
Health care0.9%
Financial services0.9%
Media & telecom0.8%
Utilities0.1%
Other0.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.